Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma.
- Moreau, Philippe
- Masszi, Tamás
- Grzasko, Norbert
- Bahlis, Nizar J
- Hansson, Markus
- Pour, Ludek
- Sandhu, Irwindeep
- Ganly, Peter
- Baker, Bartrum W
- Jackson, Sharon R
- Stoppa, Anne-Marie
- Simpson, David R
- Gimsing, Peter
- Palumbo, Antonio
- Garderet, Laurent
- Cavo, Michele
- Kumar, Shaji
- Touzeau, Cyrille
- Buadi, Francis K
- Laubach, Jacob P
- Berg, Deborah T
- Lin, Jianchang
- Di Bacco, Alessandra
- Hui, Ai-Min
- van de Velde, Helgi
- Richardson, Paul G
- TOURMALINE-MM1 Study Group
DOIAbstract
Ixazomib is an oral proteasome inhibitor that is currently being studied for the treatment of multiple myeloma
Add to ORKG